表 1.
两组患者的临床特点比较
Clinical characteristics between the two groups
| Variable | Retinopathy group (n=50) | Non-retinopathy group (n=50) | χ2/U | P |
| SLEDAI, systemic lupus erythematosus disease activity index; NPSLE, neuropsychiatric systemic lupus erythematosus. *P < 0.05. # P < 0.001. a, Fisher’s exact test. | ||||
| SLEDAI, M (P25, P75) | 22.00 (16.75, 29.00) | 10.50 (6.0, 15.25) | 223.5 | < 0.001# |
| Fever, n (%) | 13 (26.0) | 12 (24.0) | 0.053 | 0.817 |
| Rash, n (%) | 16 (32.0) | 17 (34.0) | 0.045 | 0.832 |
| Hair loss, n (%) | 8 (16.0) | 6 (12.0) | 0.332 | 0.564 |
| Mucosal ulcer, n (%) | 7 (14.0) | 6 (12.0) | 0.088 | 0.766 |
| Arthritis, n (%) | 9 (18.0) | 10 (20.0) | 0.065 | 0.799 |
| Vasculitis, n (%) | 4 (8.0) | 5 (10.0) | 0.000 | 1.000a |
| Myositis, n (%) | 4 (8.0) | 2 (4.0) | 0.177 | 0.678a |
| NPSLE, n (%) | 10 (20.0) | 4 (8.0) | 2.076 | 0.148a |
| Thrombocytopenia, n (%) | 21 (42.0) | 12 (24.0) | 3.664 | 0.056 |
| Leukopenia, n (%) | 12 (24.0) | 11 (22.0) | 0.056 | 0.812 |
| Cylindruria, n (%) | 9 (18.0) | 2 (4.0) | 3.677 | 0.051a |
| Hematuria, n (%) | 25 (50.0) | 12 (24.0) | 7.250 | 0.007* |
| Proteinuria, n (%) | 30 (60.0) | 20 (40.0) | 4.000 | 0.046* |
| Pyuria, n (%) | 23 (46.0) | 7 (14.0) | 12.190 | < 0.001# |
| Lupus nephritis, n (%) | 36 (72.0) | 23 (46.0) | 6.986 | 0.008* |
| Serositis, n (%) | 29 (58.0) | 14 (28.0) | 9.180 | 0.002* |